API Synthesis and Manufacturing, Large Molecule

October 03, 2020

Excipients must be carefully chosen to ensure optimum protection for vaccines and live biotherapeutic products.

August 20, 2020

CARBOGEN AMCIS has announced significant investments to increase manufacturing capacity in Switzerland and France.

July 08, 2020

CordenPharma added a 3000-L solid-phase peptide synthesis vessel to its GMP API facility in Boulder, CO.

July 02, 2020

RNA is easier to manipulate than DNA but challenging to deliver to the right cells.

June 04, 2020

Agreements with the PolyPeptide Group and AGC Biologics will scale up production of the Novavax Matrix-M adjuvant.

May 02, 2020

Many antibody-drug conjugate therapies are in the pipeline; however, only a handful have been approved. What are the bottlenecks?

April 02, 2020

Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.

February 17, 2020

An evaluation by USP indicates bovine heparin is a potential alternative to porcine heparin.

February 05, 2020

Synthetic biology can help researchers circumvent the challenges of traditional methods of antibody generation.

January 08, 2020

Roche will apply ProBioGen’s proprietary GlymaxX technology to boost the antibody-dependent cellular cytotoxicity activity of antibodies.